George D. Yancopoulos

Founding Scientist at Regeneron Pharmaceuticals, Inc.

George D. Yancopoulos

George D. Yancopoulos

Founding Scientist at Regeneron Pharmaceuticals, Inc.

Biography

Presently, George Damis Yancopoulos holds the position of Co-President, Director & Chief Scientific Officer at Regeneron Pharmaceuticals, Inc. and President at Regeneron Research Laboratories (a subsidiary of Regeneron Pharmaceuticals, Inc.). He is also on the board of Cold Spring Harbor Laboratory, Inc. and Member of National Academy of Sciences. He received a doctorate from Columbia University.

Overview
Career Highlights

Regeneron Research Laboratories
Regeneron Pharmaceuticals, Inc.

RelSci Relationships

1169

Number of Boards

6

Birthday

1959

Age

60

Number of Awards

1

Relationships
RelSci Relationships are individuals George D. Yancopoulos likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder, President & Chief Executive Officer at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Strong

Former Founder & Director at Peloton Therapeutics, Inc.

Relationship likelihood: Strong

Former President & Chief Executive Officer at Merck & Co., Inc.

Relationship likelihood: Strong

Chairman, Department of Molecular Genetics at The University of Texas - Southwestern Medical Center

Relationship likelihood: Strong

President at Stanford University

Relationship likelihood: Strong

President & Chief Executive Officer at Cold Spring Harbor Laboratory

Relationship likelihood: Strong

Co-Founder at Lancet Capital Partners LLC

Relationship likelihood: Strong

Executive Vice President, Research at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Strong

Vice Chairman of the Supervisory Board & Secretary at Koninklijke Philips NV

Relationship likelihood: Strong

Former Chief Executive Officer at Prudential Financial, Inc.

Relationship likelihood: Strong

Paths to George D. Yancopoulos
Potential Connections via
Relationship Science
You
George D. Yancopoulos
Founding Scientist at Regeneron Pharmaceuticals, Inc.
Education
Attendee, Valedictorian

The Bronx High School of Science was founded in 1938 and started with some 400 male students under Dr. Morris Meister, the founding principal. Each year, thousands of students from the five boroughs of New York City take a comprehensive examination containing both math and verbal questions. The exam is constantly being updated for greater testing accuracy, and the cut-off score required for admission to each of the eight specialized testing high schools varies from year to year depending upon seat availability. The school today has a population of over 3000 students.

Undergraduate Degree

Columbia University is one of the world's most important centers of research and at the same time a distinctive and distinguished learning environment for undergraduates and graduate students in many scholarly and professional fields. The University recognizes the importance of its location in New York City and seeks to link its research and teaching to the vast resources of a great metropolis. It seeks to attract a diverse and international faculty and student body, to support research and teaching on global issues, and to create academic relationships with many countries and regions. It expects all areas of the university to advance knowledge and learning at the highest level and to convey the products of its efforts to the world.

Memberships
Member
Current

The National Academy of Sciences (NAS) formed the Committee on International Security and Arms Control (CISAC) in 1980 as a permanent committee to bring the resources of the Academy to bear on critical problems of international security and arms control. CISAC, in the Policy and Global Affairs Division, draws from the nation’s finest scientific, technical, engineering and medical talent to advise the government, contribute to the work of non-governmental organizations, and inform the public about scientific and technical issues related to international security and arms control. CISAC’s work benefits from a rotating membership of distinguished scientists, policy and military experts. The Committee carries out its mandate through a variety of activities that receive financial support from public and private sponsors.

Career History
President
2000 - Current
Founding Scientist
1989 - Current

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Head of Discovery
1989 - 1997

Discovery Group focuses on investments in small-cap US equities. The firm identifies small public companies with strong operating fundamentals and invests in those that are likely to experience significant improvement in valuation based on specific anticipated business developments. They do not get involved in turnaround situations. The firm screens for companies with a unique competitive position, solid operating performance, good management teams and governance practices that are aligned with shareholders' interests. Discovery Group is an activist firm and is included in the SharkWatch50 as one the 50 most prominent activist investors.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$10K - $25K
2015

The mission of ACGT is to support the extraordinary potential offered by cell and gene-based therapies to accelerate effective and safe treatment of all types of cancer.

$100K +
2013

Columbia University is one of the world's most important centers of research and at the same time a distinctive and distinguished learning environment for undergraduates and graduate students in many scholarly and professional fields. The University recognizes the importance of its location in New York City and seeks to link its research and teaching to the vast resources of a great metropolis. It seeks to attract a diverse and international faculty and student body, to support research and teaching on global issues, and to create academic relationships with many countries and regions. It expects all areas of the university to advance knowledge and learning at the highest level and to convey the products of its efforts to the world.

Political Donations
$2,700
2017

Representative from New York's 17th Congressional District

$2,700
2015

Representative from New York's 17th Congressional District

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
Columbia University - Medal for Excellence at Commencement
Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by George D. Yancopoulos. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of George D. Yancopoulos's profile does not indicate a business or promotional relationship of any kind between RelSci and George D. Yancopoulos.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://news.relsci.com/person/george-d-yancopoulos-3228477
  • https://news.relsci.com/person/george-d-yancopoulos-3228477